The hospital chain’s shares traded between $2.27 and $2.40 on July 16. CHS shares’ closing price on July 16 was down 2.9 percent from the day prior.
In recent years, CHS has struggled with a heavy debt load and faced financial challenges. CHS ended the first quarter of 2019 with a net loss of $118 million on revenues of $3.38 billion. That’s compared to the same period of 2018, when the hospital chain recorded a net loss of $25 million on revenue of $3.69 billion.
More articles on healthcare finance:
Bernie Sanders pitches $20B hospital bailout plan
Phoenix Children’s is at an exciting inflection point, CFO says
CMS releases Quality Payment Program results: 5 takeaways
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
